510(k) Report

510(k) · Cleared

Cleared

Biotrend Oxygen Saturation and Hematocrit System

K093650510(k) TraditionalCleared Feb 17, 201084-day reviewClass II21 CFR 870.4410

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medtronic, Inc. · DTY Sensor, Blood-Gas, In-Line, Cardiopulmonary Bypass

Cleared on Feb 17, 2010 as substantially equivalent to K954501 (Medtronic Bio-Medicus, Inc., 1996) after an 84-day review. Its family tree reaches back 1 generation to 1996. 1 later device descends from it.

Decided
Feb 17, 2010
Review
84 days
Class
Class II
Product code
DTY
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K954501 (1996). 1 later device descends from it, 1 citing it directly.

Descendants, by generation 1 generation forward: 1 descendant K954501 · Biotrend Oxygen Saturation & Hematocrit System · Medtronic Bio-Medicus, Inc. · 19960
  1. Root · 1 generation backK954501 Biotrend Oxygen Saturation & Hematocrit SystemMedtronic Bio-Medicus, Inc. · 1996
  2. This deviceK093650 Biotrend Oxygen Saturation and Hematocrit SystemMedtronic, Inc. · 2010
  3. Descendant · cites it directly · 0 of its ownK133157 Tri-Optic Measurement Cell; with Balance Biosurface, with Carmeda…Medtronic, Inc. · 2014

Most influential descendants

Showing 1 of 1 · See all
  • K133157Tri-Optic Measurement Cell; with Balance Biosurface, with Carmeda Bioactive Surface…Medtronic, Inc. · 2014 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K954501Biotrend Oxygen Saturation & Hematocrit SystemMedtronic Bio-Medicus, Inc.1996—
0 (this device)K093650Biotrend Oxygen Saturation and Hematocrit SystemMedtronic, Inc.2010—
+1K133157Tri-Optic Measurement Cell; with Balance Biosurface, with Carmeda Bioactive…Medtronic, Inc.2014—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201410
FIG. 1 — Lineage of K093650, 1996–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DTY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K954501Biotrend Oxygen Saturation & Hematocrit System
Summary page 1
…DTY Classification: Class 11 Predicate Device BioTrend®Oxygen Saturation and Hemnatocrit System (K954501) Device Description The modified RioTrend Oxygen Saturation and Hemnatocrit System is an on-line monitoring…
Medtronic Bio-Medicus, Inc.1996—
†K910421Saturation/Hematocrit Monitor SystemMedtronic Vascular1991—
†K012743Trillium Tri-Optic Measurement Cell, Model TMC 25T, TMC38 T, TMC 50TMedtronic Perfusion Systems2001—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K133157Tri-Optic Measurement Cell; with Balance Biosurface, with Carmeda Bioactive Surface…Medtronic, Inc.20140

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K133157 (Medtronic, Inc., 2014) has gone furthest, with 0 descendants of its own.

How does its category compare?

All DTY devices

DTY Sensor, Blood-Gas, In-Line, Cardiopulmonary Bypass: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · DTY

1in 2010

2010: 1
2007high 1 (2010) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DTY

Too few DTY 510(k)s in any year since 2007 to give a median.

Recalls per year · DTY

2in 2010

2010: 2
2007high 2 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DTY

3in 2015

2010: 1302011: 1582012: 202013: 182014: 82015: 3
2007high 158 (2011) · low 0 (2007)2025

MAUDE reports naming product code DTY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20101—2130
20110—0158
20120—020
20130—018
20140—08
20150—03
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The BioTrend Oxygen Saturation and Hemnatocrit Systemn measures percent oxygen saturation and hemnatocrit of the blood in the extracorporeal circuit. The extracorporeal circuit is used for, but is not limited to, cardiopulmonary bypass, closed-chiest support, and limnb perfusion.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K093650: Biotrend Oxygen Saturation and Hematocrit System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K093650

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026